KDM6B and cardiomyopathy: The impact of JMJD3 on Sestrin2 expression highlights its role in modulating cellular responses to cardiotoxic stress and suggests that it could be an important therapeutic target for addressing doxorubicin-induced cardiomyopathy [102].